Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Iorio

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|June 30, 2026
Comparative real-world effectiveness and safety of benralizumab and two mepolizumab dosing regimens in eosinophilic granulomatosis with polyangiitis: a 24-month prospective single-center cohort studyMarta Codirenzi, Federica Davanzo, Luca Iorio, et al.
Clinical and Experimental Rheumatology|May 28, 2026
Switching from intravenous to subcutaneous infliximab in Behçet's disease: feasibility, safety and early outcomesEleonora Fiorin, Luca Iorio, Federica Davanzo, et al.
Rheumatology (Oxford, England)|April 5, 2023
Validation of the 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritisAlessandro Tomelleri, Roberto Padoan, Chengappa G Kavadichanda, et al.
Hypertension (Dallas, Tex. : 1979)|September 23, 2009
Pressure-induced vascular oxidative stress is mediated through activation of integrin-linked kinase 1/betaPIX/Rac-1 pathwayCarmine Vecchione, Daniela Carnevale, Alba Di Pardo, et al.
Circulation Research|December 17, 2005
Selective Rac-1 inhibition protects from diabetes-induced vascular injuryCarmine Vecchione, Alessandra Aretini, Gennaro Marino, et al.
Frontiers in Immunology|October 18, 2024
Expanding the VEXAS diagnostic workup: the role of peripheral blood cytological analysisChiara Baggio, Francesca Oliviero, Roberto Padoan, et al.
Frontiers in Immunology|December 18, 2025
VEXAS syndrome in rheumatology practice: features from a multicenter cohort in north-east ItalySara Bindoli, Greta Morello-Pasin, Irina Guidea, et al.
Rheumatology (Oxford, England)|February 24, 2026
Clinical outcomes of subglottic stenosis in granulomatosis with polyangiitis: results of an international multicenter observational studyGabriele Domenico Gallina, Marco Lanzillotta, Sara Maggioni, et al.
Rheumatology (Oxford, England)|April 26, 2025
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre studyPaolo Delvino, Luca Quartuccio, Joanna C Robson, et al.
Rheumatology (Oxford, England)|June 30, 2026
Prognostic value of quantifying vascular inflammation through ultrasound in patients with giant cell arteritis: the MAGiCUS studyJuan Molina-Collada, Sharon Cowley, Colm Kirby, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|June 30, 2026
Comparative real-world effectiveness and safety of benralizumab and two mepolizumab dosing regimens in eosinophilic granulomatosis with polyangiitis: a 24-month prospective single-center cohort studyMarta Codirenzi, Federica Davanzo, Luca Iorio, et al.
Clinical and Experimental Rheumatology|May 28, 2026
Switching from intravenous to subcutaneous infliximab in Behçet's disease: feasibility, safety and early outcomesEleonora Fiorin, Luca Iorio, Federica Davanzo, et al.
Rheumatology (Oxford, England)|April 5, 2023
Validation of the 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritisAlessandro Tomelleri, Roberto Padoan, Chengappa G Kavadichanda, et al.
Hypertension (Dallas, Tex. : 1979)|September 23, 2009
Pressure-induced vascular oxidative stress is mediated through activation of integrin-linked kinase 1/betaPIX/Rac-1 pathwayCarmine Vecchione, Daniela Carnevale, Alba Di Pardo, et al.
Circulation Research|December 17, 2005
Selective Rac-1 inhibition protects from diabetes-induced vascular injuryCarmine Vecchione, Alessandra Aretini, Gennaro Marino, et al.
Frontiers in Immunology|October 18, 2024
Expanding the VEXAS diagnostic workup: the role of peripheral blood cytological analysisChiara Baggio, Francesca Oliviero, Roberto Padoan, et al.
Frontiers in Immunology|December 18, 2025
VEXAS syndrome in rheumatology practice: features from a multicenter cohort in north-east ItalySara Bindoli, Greta Morello-Pasin, Irina Guidea, et al.
Rheumatology (Oxford, England)|February 24, 2026
Clinical outcomes of subglottic stenosis in granulomatosis with polyangiitis: results of an international multicenter observational studyGabriele Domenico Gallina, Marco Lanzillotta, Sara Maggioni, et al.
Rheumatology (Oxford, England)|April 26, 2025
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre studyPaolo Delvino, Luca Quartuccio, Joanna C Robson, et al.
Rheumatology (Oxford, England)|June 30, 2026
Prognostic value of quantifying vascular inflammation through ultrasound in patients with giant cell arteritis: the MAGiCUS studyJuan Molina-Collada, Sharon Cowley, Colm Kirby, et al.
Pageof 4